跳至主要内容
临床试验/CTRI/2011/06/001825
CTRI/2011/06/001825已完成2 期

CLINICAL STUDY ON HYPERLIPIDEMIA AND COMPARATIVE EVALUATION OF EFFICACY OF A COMPOUND UNANI FORMULATION (SAFOOF-E-MUAHAZZIL) AND COMPRESSED TABLET OF SAFOOF-E-MUHAZZIL IN ITS MANAGEMENT

Department of Moalejat Medicine Faculty of Medicine1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2010年5月24日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
hyperlipidemia

研究概览

简要总结

The purpose of this study is to evaluate the comparative effect of a compound Unani formulation (Safoof-e-Muhazzil) and compressed tablet of same drug i.e., Safoof-e-Muhazzil in hyperlipidemia against a standard control i.e, Atorvastatin  and to establish their tolerability and efficacy.  Serum cholesterol, VLDL, LDL, HDL, and Triglycerides together with BMI, Waist To Hip Ratio and Blood Pressure will be used to compare the status of Blood Lipids,obesity and Hypertension  before and after treatment, and scored to determine the efficacy of the treatment.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Person aged
  • 70 Years M/F Patients willing to sign consent form & participate in Clinical Trial voluntarily. Hyperlipidemic.

排除标准

  • Persons below 20 yrs and Above 70 yrs of age Pregnancy Liver diseases Renal diseases Diabetes mellitus Type II Alcoholic AIDS Thyroid Disease Drug intake ?
  • Corticosteroids, Diuretics, Beta-blockers, Oral contraceptives, Cyclosporin, Androgens & Retinoids.

结局指标

主要结局

hyperlipidemia

时间窗: 0,2,4, and 6 weeks

次要结局

  • obesity, hypertension(0,2,4, and 6 weeks)

研究者

发起方
Department of Moalejat Medicine Faculty of Medicine
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验